Latest filing published 10 Sept 2026 for KESTRA MEDICAL TECHNOLOGIES, LTD., €84k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jeffrey Lawrence Schwartz: trading record in brief
Jeffrey Lawrence Schwartz is a declared insider at 4 companies (board member); the most frequent names are SpringWorks Therapeutics, Inc., Kestra Medical Technologies, Ltd. and BCLS Acquisition Corp. The record holds 9 filings, for trades running from 26 October 2020 to 9 September 2026.
On the market, this insider has only sold: 2 sales, €47.2M in total. Outside the open market, there are 7 share grants. So far in 2026, the count stands at no purchases and 1 sale.
The record was last updated on 10 September 2026 with a share grant in Kestra Medical Technologies, Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey Lawrence Schwartz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,890 shares@ US$25.178Common SharesSEC:0000950130-26-000223:0
- 7,217 sharesCommon SharesSEC:0000950130-26-000223:1
- 10,909 sharesCommon SharesSEC:0000950170-25-113627:0
- 14,300 shares0Class A Common StockSEC:0000950170-24-065323:0
- 4,648 shares0Common StockSEC:0000899243-23-013903:0
- 1,750,000 shares@ US$28.50100.0% of flowCommon StockSEC:0000899243-23-009117:0
- 4,818 shares0Common StockSEC:0000899243-22-019105:0
- 1,106 shares0Common StockSEC:0000899243-21-020446:0
8 of 8 declarations
